Great job for shareholders buy "Cal et al" This is HUUUUGE ... multiple phase 2's??
This is now worth close to 2B CAD or about 18 times that of EDTXF..
AND..being S O L D to the public...I love you Canada..I love Canadien Bio
PAY ATTENTION to the depressed stuff insiders like to BUY on the cheap!
Trillium Therapeutics closes offering for $149M (U.S.)
2020-09-16 16:16 ET - News Release
Dr. Jan Skvarka reports
TRILLIUM CLOSES US$150 MILLION PUBLIC OFFERING OF COMMON SHARES
Trillium Therapeutics Inc. has closed its previously announced underwritten public offering of common shares of the company at a public offering price of $13 (U.S.) per common share. It sold 11.5 million common shares in the offering, including the full exercise by the underwriters of their option to purchase up to an additional 1.5 million common shares.
The gross proceeds from the offering were $149.5-million (U.S.), before deducting underwriting commissions and other offering expenses. The company intends to use the net proceeds of the offering for its continuing and planned clinical trials for its CD47 program, including drug supply, and for working capital and general corporate purposes.
"We would like to thank all investors who placed their trust in both our unique CD47 assets as well as Trillium people. We are committed to speedily advance our investigational program into multiple phase 2 trials, and further drive evolution of the oncology treatment paradigm toward greater adoption of novel, groundbreaking immunotherapies," said Dr. Jan Skvarka, Trillium's president and chief executive officer